These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Fang CJ; Fremeaux-Bacchi V; Liszewski MK; Pianetti G; Noris M; Goodship TH; Atkinson JP Blood; 2008 Jan; 111(2):624-32. PubMed ID: 17914026 [TBL] [Abstract][Full Text] [Related]
11. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome. Le Quintrec M; Zuber J; Moulin B; Kamar N; Jablonski M; Lionet A; Chatelet V; Mousson C; Mourad G; Bridoux F; Cassuto E; Loirat C; Rondeau E; Delahousse M; Frémeaux-Bacchi V Am J Transplant; 2013 Mar; 13(3):663-75. PubMed ID: 23356914 [TBL] [Abstract][Full Text] [Related]
12. Atypical hemolytic uremic syndrome: update on the complement system and what is new. Hirt-Minkowski P; Dickenmann M; Schifferli JA Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363 [TBL] [Abstract][Full Text] [Related]
13. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990 [TBL] [Abstract][Full Text] [Related]
14. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP. Cruzado JM; de Córdoba SR; Melilli E; Bestard O; Rama I; Sánchez-Corral P; López-Trascasa M; Navarro I; Torras J; Gomà M; Grinyó JM Am J Transplant; 2009 Jun; 9(6):1477-83. PubMed ID: 19459807 [TBL] [Abstract][Full Text] [Related]
15. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. Fremeaux-Bacchi V; Kemp EJ; Goodship JA; Dragon-Durey MA; Strain L; Loirat C; Deng HW; Goodship TH J Med Genet; 2005 Nov; 42(11):852-6. PubMed ID: 15784724 [TBL] [Abstract][Full Text] [Related]
16. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452 [TBL] [Abstract][Full Text] [Related]
17. Complement therapy in atypical haemolytic uraemic syndrome (aHUS). Wong EK; Goodship TH; Kavanagh D Mol Immunol; 2013 Dec; 56(3):199-212. PubMed ID: 23810412 [TBL] [Abstract][Full Text] [Related]
18. Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations. Kim JJ; Goodship TH; Tizard J; Inward C Pediatr Nephrol; 2011 Nov; 26(11):2073-6. PubMed ID: 21717289 [TBL] [Abstract][Full Text] [Related]
19. Atypical Hemolytic Uremic Syndrome Triggered by Acute Pancreatitis in a Patient with a Membrane Cofactor Protein (CD46) Genetic Variant. Mochizuki K; Toda N; Fujita M; Kurahashi S; Hirashima H; Yoshioka K; Kitagawa T; Ishii A; Komiya T Intern Med; 2024 Oct; 63(19):2651-2654. PubMed ID: 38403763 [TBL] [Abstract][Full Text] [Related]